Beaumont Financial Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Beaumont Financial Advisors, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $51.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$51.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 115,122 | $28.1M |
| ABTABBOTT LABORATORIES | 69,183 | $7.1M |
| LLYELI LILLY & Co | 4,681 | $4.3M |
| PMPhilip Morris International Inc | 19,495 | $3.2M |
| MRKMerck & Co., Inc. | 15,089 | $1.8M |
| ABBVAbbVie Inc. | 8,027 | $1.7M |
| AMGNAMGEN INC | 4,159 | $1.5M |
| RVMDREVOLUTION MEDICINES, INC. | 9,800 | $953K |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 10,240 | $642K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,082 | $563K |
| BMYBRISTOL MYERS SQUIBB CO | 8,702 | $528K |
| MCKMcKesson Corporation | 449 | $389K |
| RIOTRiot Platforms, Inc. | 30,824 | $381K |
| GILDGILEAD SCIENCES, INC. | 1,687 | $235K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 510 | $228K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.